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Introduction
Gender verification of female athletes during international sporting 
events is not a recent issue.  The possibility that men, who have in 
most cases an unfair biological advantage, could masquerade as 
female athletes has been a concern since women started competing 
in individual athletic events.  The history, methods and issues related 
to gender verification have been reviewed on a regular basis in the 
scientific literature over the years.1-6  Although athletes from many 
nations have been subject to the various verification methods used 
over the years, this issue has, from a South African perspective, re-
cently been extensively debated in the public domain in an unprec-
edented way.  Caster Semenya, the women’s 800 m gold medallist 
at the Berlin world championships during August 2009, refuelled the 
debate on gender testing in sport.  The purpose of this review is to 
investigate the historical and current practises and understanding of 
gender verification within the medical and scientific community.      
Gender, sex and performance
The term gender verification has predominately been used in the sci-
entific literature 1-5 and by various sporting bodies, including the In-
ternational Olympic Committee (IOC)5 and International Association 
of Athletics Federations (IAAF) 7 to describe and debate the issue 
of testing and verifying that only eligible athletes compete in female 
events.  Gender is however a social construct comprising not only 
biological but also social and other non-biological differences be-
tween males and females.8  The term sex, on the other hand, refers 
solely to the biological difference between individuals and in the vast 
majority of cases can  be divided into two clear categories: male and 
female.8  Although we recognise that gender issues are important in 
the sporting arena, the term sex verification or testing will be used in 
this review to highlight the biological differences between male and 
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Fig. 1. Relative differences between male and female world records for various athletic field,
track and road events. The world records for the individual male events is on average 12.6±2.3 %
(ranging from 9.2% to 17.6%) faster than the female events. SC = steeple chase; m = metres;
km = kilometres.
Fig. 1.  Relative differences between male and female world re-
cords for various athletic field, track and road events. The world 
records for the individual male events is on average 12.6±2.3 % 
(ranging from  9.2% to 17.6%) faster than the female events.  SC 
= st epl  chase; m = metres; km = kil metres.
female athletes which generally give male athletes an unfair advan-
tage over their female counterparts.9  
With the exception of the equestrian events, where male and 
female athletes compete together in all Olympic events (www.
olympic.org), male athletes have a performance advantage over 
female athletes.  This is illustrated by a comparison between male 
and female world records in track and field events, as well as the 
standard marathon, where men’s world records are between 9% and 
18% better than women’s records for those events allowing a direct 
comparison to be made (Fig. 1).  Similar performance advantages 
can be measured in cycling, speed-skating and swimming events 
(data not shown).  As a result of this performance difference, 
women compete in a category separate to men to ensure equality 
of competition.  In addition to sex, weight classes are also used to 
categorise athletes in open competition where weight differences 
are believed to have a biological advantage.  These sports include, 
among others, boxing, weight lifting, and the martial arts disciplines 
(www.olympic.org).  Unlike weight, which can be accurately 
determined using a calibrated scale, the science of sex verification is 
more complex and controversial.
Stop men competing as women
Athletes, coaches, officials, the media and spectators have always 
been aware and concerned that there is the potential that male ath-
letes would deliberately disguise themselves as women and com-
pete as female athletes in individual events.  This issue attracted 
much media attention during the 1936 Berlin Olympic Games where 
Herman Ratjien competed in the high jump for Germany as Dora 
Ratjen.3  Although ‘Dora’ finished only 4th in that competition, ‘she’ 
eventually set a world record at the European Championships 2 
years later (http://en.wikipedia.org/wiki/Dora_Ratjen).  It has been 
alleged that Ratjen was forced to disguise himself as a female ath-
lete by the Nazis.3  It is also reported that due to abnormalities with 
his genitalia, Herman was registered as Dora at birth and raised as 
a girl (http://en.wikipedia.org/wiki/Dora_Ratjen).  This case, as well 
as other accusations of male athletes masquerading as females dur-
ing the Berlin games,6 as well as rumours and innuendos during the 
1960 Rome Olympic games prompted the IOC and IAAF to establish 
rules to stop men cheating during competition thereby enabling fe-
male athletes to compete on an equal basis.1-4,6
Sex verification – not a simple problem
The Berlin games also highlighted that sex verification is not a simple 
scientific and medical problem to solve.  Polish-born Stella Welsh 
(Stalislawa Walasiewicz), who had moved to the USA in 1932, and 
the American Helen Stephens both competed in the women’s 100 m 
sprint.6 Walsh had won the 100 m gold medal in 1932, and was spec-
ulated by many to be male, receiving the nickname ‘Stella the Fella’ 
from the media (http://en.wikipedia.org/wiki).6 Helen Stephens beat 
Walsh in the 100 m event at the 1936 games, and although there 
was no official gender testing during the Games, Stephens passed 
a crude examination of her external genitalia after she was accused 
of being a male by Stella Welsh.6 Interestingly, Stella Welsh was 
discovered to have ambiguous genitalia and abnormal sex chromo-
somes during an autopsy after she was a victim of a shooting inci-
dent in 1980,6 highlighting that sex verification during sporting events 
would not only identify those cheating but also athletes with a rare 
intersex condition. An unanswered question is whether these inter-
sex conditions might confer a sporting advantage to certain individu-
als who compete as females, and whether this advantage should 
form the basis for exclusion from female competition.  As will be dis-
cussed in this review, one cannot exclude the inevitable possibility 
that female athletes with a rare intersex disorder could be unfairly 
disqualified and barred from competing in athletic events, especially 
if inappropriate testing is done and the issue is poorly managed.  In 
addition, the potential for long-term psychological harm to the athlete 
concerned can not be under-estimated. 
Disorder(s) of sex development
Intersex is a rare disorder which is usually identified at birth by the 
atypical appearance of the genitalia, making sex assignment diffi-
cult. The incidence has been estimated as approximately 1 in 5 000 
births, but can be as high as 1.7% when conditions such as Turner’s 
and Kleinfelters’s syndrome are included.6  The classification of the 
intersex disorders is challenging and controversial, but these condi-
tions were recently grouped under the collective name disorder(s) 
of sex development (DSD) by the international intersex consensus 
conference.10  DSD is not a single disorder but rather a spectrum 
of conditions ranging from those with ambiguous external genitalia, 
those with external female genitalia and varying degrees of internal 
testis.2,10
History of sex verification
The current practices and beliefs with respect to the science and 
management of sex testing in sport need to be understood in its 
historical context.  When sex verification was first introduced in in-
ternational sporting competition during the early 1960s, female ath-
letes underwent physical examinations where they stood before a 
committee of experts, in what became known as the ‘nude parade’.6 
This resulted in widespread resentment by the athletes, prompting 
the IOC to seek other simpler, objective and more dignified methods 
of sex testing.  The sex chromatin (or buccal smear) test, which re-
quires the identification of Barr bodies during microscopic examina-
tion of cells scraped from the inner lining of the athlete’s cheek, was 
developed and first introduced during the 1968 Mexico City Olympic 
Games.
Human DNA is packed into 22 pairs of autosomes and one pair 
of sex chromosomes in most cell types in our bodies.  Under normal 
circumstances, females possess two X sex chromosomes and males 
one Y chromosome and one X chromosome.  The extra female X 
chromosome is inactivated during development to form a Barr body 
in the nucleus of cells.  The presence of a Barr body is therefore an 
indication that the cells being tested originate from a female, whereas 
the absence of a Barr body indicates that the cells originated from a 
male.  Since there is a direct relationship between chromosomal and 
anatomical sex for the majority of people, this test would be accurate 
in most cases. There are however a number of genetic disorders 
which interfere with the normal process of sex development and 
lead to contradictory findings between anatomical and chromosomal 
sex.10  As mentioned previously, these conditions are collectively 
referred to as disorders of sex development (DSDs).10  It is the 
potential identification of such an individual athlete during sex testing 
during athletic events that is problematic.
DSDs can be caused by several combinations of abnormal sex 
chromosomes.6,10 For example, individuals with only one X sex 
chromosome have a female appearance (Turner’s syndrome), while 
individuals with two X and one Y chromosome (XXY, Klinefelter’s 
syndrome) are usually infertile men.2  The Barr body test would 
identify these individuals as female, which would allow men with 
Klinefelter’s syndrome to compete as females.  Women with Turner’s 
syndrome would ‘test as men’ due to the absence of a second 
sex chromosome and therefore a Barr body.  It should however 
be noted that not all athletes with abnormal sex chromosomes 
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would potentially have a biological advantage over their female 
counterparts with normal sex chromosomes, and both Turner’s and 
Klinefelter’s syndrome would be unlikely to confer a performance 
advantage.  Rather, it is disorders affecting androgen function, which 
are discussed subsequently, that present the problem of potential 
performance advantages to females.  It is also possible for different 
cells in a individual to contain different sex chromosomes.3 This is 
referred to as mosaicism, where some cells may present with XX 
and XXY chromosomes.  Other possibilities include XX and XY cell 
combinations, or X and XY cell combinations.3
An illustration of this complexity and the implications for testing is 
the case of Ewa Klobukowska, a Polish sprinter who won gold and 
silver in the women’s 100 m and 200 m sprints at the 1966 European 
Athletics Championships in Budapest.11  She was also a member of 
the winning team in the 4X100 m relay event.  Prior to the Budapest 
championships, she won gold and bronze medals at the 1964 Tokyo 
Olympic Games for the 4X100 m relay and 100 m, respectively (http://
en.wikipedia.org/wiki/Ewa_Klobukowska).  Although she passed 
a gynaecological exam during the Budapest championships, she 
was the first Olympic medal-winning athlete to fail a sex chromatin 
gender test in 1967.  Although her disorder was correctly, due to 
confidentiality and medical ethics, never officially revealed, she was 
nevertheless stripped of her medals.11  It has been alleged that this 
was a result of an XX/XXY mosaicism, although this was never 
officially revealed (http://en.wikipedia.org/wiki/Ewa_Klobukowska).11 
The implication is that Barr body analysis is more likely to exclude 
athletes unfairly than to detect those who cheat.   
In addition to these conditions, there are also individuals with a 
female appearance who have a DSD with male sex chromosomes, 
the so-called XY females.1,6  These individuals have apparently 
normal male chromosomes, but develop to adulthood as women. 
The disorders responsible for this phenotype can broadly be divided 
into (i) disorders in androgen synthesis or action and (ii) disorders of 
testicular development.6  An example of the former group of disorders 
is complete or partial androgen insensitivity syndrome (AIS).1 
Individuals with AIS have testes (which can be internal) that produce 
normal amounts of testosterone.  However, abnormal androgen 
receptors, which are partly or completely insensitive to androgens, 
result in the development of secondary female characteristics and 
musculature.  Various grades of AIS exist, ranging from complete 
AIS to partial AIS with a very mild impact on sexual development.1 
This may impact on performance, since androgens are largely 
responsible for virilisation, including muscle development, which 
may confer a performance advantage.  Individuals with partial 
AIS may thus develop sexual characteristics of a female, and be 
identified and raised female, while possessing some level of athletic 
performance advantage.  
A further complication is somatic mosaicism of the androgen 
receptors, as a result of de novo mutations after the zygotic 
stage.12  These mutations may result in different levels of sensitivity 
to androgens, leading to virilisation at puberty, despite childhood 
development as female with respect to the genitalia.12  This may 
have further implications for performance. Santhi Soudarajan, 
an Indian middle distance runner, was stripped of her 2006 Asian 
Games silver medal in the 800 m event after failing gender testing, 
allegedly as a result of this condition (http://en.wikipedia.org/wiki/
Santhi_Soudarajan).  
Genetic screening increases in complexity
Although the IAAF stopped compulsory sex testing in 1991,3 the IOC 
continued to screen all female participants, but replaced the Barr 
body test with a more complex screening process which involved 
PCR analysis to detect the SRY gene, which is found on the male Y 
chromosome.3 The product of this gene was thought to be essential 
for the differentiation of the internal foetal gonad into testis, which 
ultimately produces the male phenotype.6  It is now known that this 
test also has limitations, since other genes are also required for tes-
tis development and in addition, it has been reported that individuals 
with XX sex chromosomes, and therefore no SRY gene, can have 
testes.6  Further, it is also possible for the SRY gene to exist on the 
X-chromosome as a result of translocations during meiosis.11 
This test was used during the 1992 Winter Olympics and 1996 
Atlanta Olympic Games, where all women competitors submitted a 
sample which was analysed.  In 1992, 2 406 tests were conducted, 
with 5 positive samples for the SRY gene and in 1996 there were 8 
positive SRY gene test out of 3 387 tests.3,5  These individuals were 
entered as females, but possessed the SRY gene and in theory, 
excluding a translocation event during meiosis, a Y-chromosome. 
The incidence (approximately 1 in 400) during the 1992 and 1996 
games using the SRY gene test were similar to the incidence 
reported from 1972 to 1990, where 13 positive tests were reported 
out of 6 561 (approximately 1 in 500).1,2  
Seven of the 8 athletes in the Atlanta games had AIS and the eighth 
athlete had a condition called α-5-reductase deficiency,3,5,6 which 
results in the failure to convert testosterone to dihydrotestosterone, an 
androgen which is essential for the in utero development of external 
male genitalia.  These individuals develop externally as females, 
despite having high levels of testosterone and internal testes.  As is 
the case with AIS, the elevated levels of testosterone, relative to other 
females, is thought to confer some performance advantage, though 
no studies have quantified the possible magnitude of this difference. 
In the 2000 Olympics, all 8 athletes were cleared to compete, though 
the reasons for this clearance were never disclosed.5,6  There are 
theoretical reasons why athletes with both partial AIS and α-5-
reductase deficiency may have performance advantages, but we are 
not aware of the grounds for clearing these athletes for competition. 
Eventually the IOC stopped compulsory testing of female athletes 
in 1999.3,5
Interestingly, it has recently been reported that since 2005, four 
athletes had been asked to retire from athletics by the IAAF as a 
result of gender testing, while three others had been permitted to 
continue their careers (/www.sport24.co.za/Content/OtherSport/
262/97ea563d0618444c808b8057e9c020a6/10-09-2009-02-32/
Semenya_made_to_wait).  There have, for reasons of medical 
confidentiality, been no further descriptions or explanations of these 
cases, and the grounds for the different outcomes of the testing 
process for these individuals.  This highlights the complexity of the 
actions that are taken against athletes, since no data exist on how 
DSDs may confer a performance advantage to athletes.
In an excellent essay entitled ‘Intersex and the Olympic Games’, 
Richie et al.6 summarise the effects of gender testing as follows: 
‘As our understanding of gender and sexual identify increased 
…, it became increasingly apparent to scientists and athletes 
alike that determination of sex is derived from far more than our 
genotype. … Gender testing was initially welcomed by female 
athletes as a method of preventing “cheaters”. However, it has 
become apparent that the discrimination against those with DSD 
was unfair and detrimental to the sport.’  They continue to mention 
that: ‘Gender testing in athletics has never identified an individual 
deliberately misrepresenting their gender. Testing has, however, 
created controversy and embarrassment for a significant number 
of female athletes competing, often unknowingly, with some form of 
intersex disorder. Indeed, there is no evidence that female athletes 
with DSDs have displayed any sports relevant physical attributes 
which have not been seen in biologically normal female athletes. 
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However, numerous female athletes have been unfairly barred from 
competing’.6
IAAF consensus statement
As a result of controversies surrounding testing and the potential for 
unfairly barring athletes from competing, the IAAF Medical and Anti-
Doping Commission published the IAAF Policy on Gender Verification 
in 2006.7  In it they state that there will be no compulsory, standard 
or regular gender verification during IAAF-sanctioned events.  How-
ever, the policy continues to state that in resolving cases that may 
arise due to any ‘suspicion’ or if there is a ‘challenge’, determination 
should not be done solely on laboratory-based sex determination. 
Instead the athlete concerned could be asked to attend a medical 
evaluation by a multidisciplinary panel of experts consisting of a (i) 
gynaecologist, (ii) endocrinologist, (iii) psychologist, (iv) international 
medicine specialist, and (v) expert on gender/transgender issues.
To our knowledge there are no published studies in the scientific 
literature that have specifically shown or suggested that any of the 
DSDs give an unfair advantage to the individual.  Instead the IAAF 
groups the DSD conditions into two broad categories, (i) those that 
accord no advantage over other females and (ii) those that may 
accord some advantage but are nevertheless acceptable.7 The 
former category consists of complete or near-complete AIS, gonadal 
dysgenesis and Turner’s syndrome. The latter group consists of 
congenital adrenal hyperplasia, androgen-producing tumours and 
anovulatory androgen excess (polycystic ovary syndrome).7  In all 
cases, the IAAF states that if testes are present, they should be 
removed to avoid malignancy.7
The Canadian Academy of Sports Medicine (CASM) 
recommendations
The 1997 CASM position statement on sex testing (gender verifi-
cation) in sport suggests that there is no evidence that the initial 
justification and reasons for sex testing, which were to prevent men 
from masquerading as female athletes, are relevant today.9  They 
mention that (i) the use of communal dressing rooms and showers, 
(ii) the clothing worn by female athletes, (iii) current protocols used 
for drug testing in urine, and (iv) the athlete’s personal and sport-
ing history, significantly reduces the likelihood of men competing as 
women at an international level. 
The CASM also recommends that: ‘Individuals raised as females 
and are psychologically and socially females from childhood should 
be eligible to compete in women’s competition regardless of their 
chromosomal, gonadal and hormonal sex’.9  Furthermore, they 
recommend that: ‘Women athletes who have developed greater 
than average muscle mass, whether due to extreme training 
programmes or to genetic abnormalities such as congenital adrenal 
hyperplasia, incomplete/partial AIS or chromosomal mosaicism 
should be accepted as part of the normal range of variation, similar 
to individuals who have grown to extreme heights.’9  The CASM 
agrees with the current practice of disqualifying women (and men) 
who have increased their muscle mass by using steroids or other 
banned performance-enhancing drugs.9
This position is likely to be contentious among some female 
athletes, since it holds that these individuals should be accepted as 
falling within the ‘normal range of variation’.  This definition of ‘normal 
variation’ challenges the boundary that exists between male and 
female competitions which, as we have described, is not as clear-
cut or easily identifiable as was first thought when sex testing was 
introduced.  
Theoretically, DSDs which result in elevated testosterone levels 
may confer some performance advantage over other females, if 
the testosterone has a biological effect on the tissues.  However, 
evidence has not yet been provided, primarily due to the rarity of such 
conditions, as well as ethical matters pertaining to confidentiality.  It 
may prove impossible to determine conclusively whether performance 
advantages exist or not.  Whether any performance advantage that 
may exist falls within normal variation is also a contentious issue, 
because, referring to the CASM position stand example, athletes do 
not compete in categories of height.  The classification of athletes into 
male and female categories requires that some boundary between 
the classes remain in place, and the contention is around whether 
normal variation may in fact move an individual across this boundary, 
and should be disallowed.  At present, there is no scientific evidence 
to support or refute this position.
Conclusion
The process and management of sex verification is enormously 
complex and poses challenges not only to the biological description 
of male and female, but also to social and cultural  characterisations 
of gender and sex.  The process of verification has evolved over 70 
years, having first begun as a means to deter deliberate cheating, 
and then evolving into a process that aims to ensure fair competi-
tion in the face of conditions that are thought to confer performance 
advantages.  However, while a range of conditions and disorders 
have been identified, authorities are seemingly no closer to estab-
lishing precisely how these conditions affect performance, and many 
athletes appear to have been unfairly excluded from competition. 
Recognising this, a sub-committee was formed at the 13th Biennial 
Conference of the South African Sports Medicine Association (SAS-
MA) in Durban on  21 - 23 October 2009 to draft a position statement 
on gender and sex verification for the South African context.
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